Cargando…

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma

Introduction. To determine the value of a FDG-PET-CT scan in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) prior to chemoradiotherapy. Materials and Methods. Consecutive patients with stage III or IV HNSCC who had undergone a staging FDG-PET-CT scan prior to chemoradio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prestwich, Robin J. D., Bhatnagar, Priya, Chowdhury, Fahmid U., Patel, Chirag N., Dyker, Karen E., Coyle, Catherine, Şen, Mehmet, Scarsbrook, Andrew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324911/ https://www.ncbi.nlm.nih.gov/pubmed/22548190 http://dx.doi.org/10.5402/2012/636379

Ejemplares similares

Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy
por: Scarsbrook, Andrew, et al.
Publicado: (2016)

Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management
por: Subedi, Navaraj, et al.
Publicado: (2013)

Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours
por: Albazaz, Raneem, et al.
Publicado: (2013)

Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort
por: Zhong, Jim, et al.
Publicado: (2020)

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer
por: D Prestwich, Robin J, et al.
Publicado: (2010)

Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
por: Prestwich, Robin, et al.
Publicado: (2018)

Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
por: Oksuz, Didem C, et al.
Publicado: (2011)

Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma
por: Billingsley, Sarah, et al.
Publicado: (2023)

Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience
por: Subesinghe, Manil, et al.
Publicado: (2013)

Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma
por: Iyizoba-Ebozue, Zsuzsanna, et al.
Publicado: (2022)

Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma
por: Bird, David, et al.
Publicado: (2015)

Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study
por: Subesinghe, Manil, et al.
Publicado: (2015)

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice
por: Figen, Metin, et al.
Publicado: (2020)

Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume
por: Scarsbrook, Andrew, et al.
Publicado: (2017)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma
por: Frood, Russell, et al.
Publicado: (2022)

Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
por: Ermiş, Ekin, et al.
Publicado: (2015)

Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience
por: Duru Birgi, Sumerya, et al.
Publicado: (2015)

Retropharyngeal Lymph Node Involvement in Oropharyngeal Carcinoma: Impact upon Risk of Distant Metastases and Survival Outcomes
por: Iyizoba-Ebozue, Zsuzsanna, et al.
Publicado: (2019)

Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma
por: Frood, Russell, et al.
Publicado: (2022)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Metabolic patterns on [(18)F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Accuracy of [(18)Fluorine]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography-Computed Tomography Response Assessment Following (Chemo)radiotherapy for Locally Advanced Laryngeal/Hypopharyngeal Carcinoma
por: Slevin, Finbar, et al.
Publicado: (2017)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT
por: Matoba, Munetaka, et al.
Publicado: (2015)

The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy
por: Young, Caroline A, et al.
Publicado: (2014)

Value of pre-treatment (18)F-FDG PET/CT radiomics in predicting the prognosis of stage III-IV colorectal cancer
por: Wang, Na, et al.
Publicado: (2023)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial
por: Konert, T., et al.
Publicado: (2019)

FDG-PET/CT pitfalls in oncological head and neck imaging
por: Purohit, Bela S., et al.
Publicado: (2014)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005)

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2019)

FDG–PET. A possible prognostic factor in head and neck cancer
por: Halfpenny, W, et al.
Publicado: (2002)

(18)F-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study
por: Dang, Ya-Zheng, et al.
Publicado: (2019)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_omu1agfg8l11nvdh8fpbvntajm